Anixa Biosciences Inc (ANIX)

PriceLoading quote

Financial charts

Revenue

Net income

Free cash flow

Total cash / debt

CashTotal debt

Financial statements

16 annual periodsNewest to oldest
2025202420232022202120202019201820172016201520142013201220112010
Revenue$210,000$210,000$512,000$250,000$1.1M$362,500$300,000$9.3M$3.7M$388,850$940,010$1.0M$730,675
Research & development$5.1M$6.4M$4.8M$6.7M$6.2M$4.4M$5.5M$6.8M$1.6M$1.6M$711,391$2.2M$3.1M$3.0M
Operating expenses$7.9M$9.0M$6.5M$7.2M$5.6M$5.8M$6.4M$6.5M$4.8M
Operating income−$11.7M−$13.8M−$11.0M−$13.9M−$13.1M−$10.0M−$11.9M−$14.3M−$6.1M−$4.5M−$944,759−$5.0M−$7.9M−$4.1M−$5.0M−$5.2M
EBITDAderived−$11.4M−$14.3M−$6.0M−$4.5M−$932,244−$4.1M−$5.0M
Net income−$10.9M−$12.6M−$9.8M−$13.6M−$13.0M−$10.0M−$11.6M−$14.0M−$5.0M−$5.0M−$1.4M−$9.6M−$10.1M−$4.3M−$7.4M−$5.2M
Basic EPSper diluted share-$0.34-$0.39-$0.32$0.45-$0.45-$0.45-$0.59-$0.79-$0.58-$0.57-$16.00-$1.10-$0.05-$0.02-$0.04-$0.03
Diluted EPSper diluted share-$0.34-$0.39-$0.32$0.45-$0.45-$0.45-$0.59-$0.79-$0.58-$0.57-$16.00-$1.10-$0.05-$0.02-$0.04-$0.03

Insider buys & sells

Jul 1, 2024Jun 30, 2026
Buys22$540.9K disclosed value
Sells (SEC code S)0$0.00 disclosed value
22 recent transactions
TransactionInsiderTypeSharesPriceValueOwned after
Jun 16, 2026Form 4Titterton Lewis H jrDirectorBuyCommon Stock2.8K$2.64$7.5K972.2K
Jun 12, 2026Form 4KUMAR AMITChief Executive OfficerBuyCommon Stock21.0K$2.50$52.5K630.8K
Jan 28, 2026Form 4Baskies Arnold MDirectorBuyCommon Stock10.0K$3.04$30.4K135.0K
Jul 31, 2025Form 4Titterton Lewis H jrDirectorBuyCommon Stock10.0K$3.08$30.8K953.3K
Jul 30, 2025Form 4KUMAR AMITChief Executive OfficerBuyCommon Stock5.0K$3.16$15.8K579.9K